AES
31
-9
KIM
66
2
MTB
56
-3
KMB
33
2
CFG
54
-4
CAH
47
15
DG
23
2
DGX
39
-4
CI
52
7
IVZ
52
6
ETR
66
-9
MA
58
3
FLS
67
4
JWN
50
-2
HSY
31
2
O
30
-5
TXN
48
3
BMY
43
-3
EQT
39
-3
AEE
50
-3
AES
31
-9
KIM
66
2
MTB
56
-3
KMB
33
2
CFG
54
-4
CAH
47
15
DG
23
2
DGX
39
-4
CI
52
7
IVZ
52
6
ETR
66
-9
MA
58
3
FLS
67
4
JWN
50
-2
HSY
31
2
O
30
-5
TXN
48
3
BMY
43
-3
EQT
39
-3
AEE
50
-3
Financhill
Back

Intelligent Bio Solutions 10K Form

Sell
34

INBS
Intelligent Bio Solutions

Last Price:
1.40
Seasonality Move:
13.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INBS News And Ratings

See the #1 stock for the next 7 days that we like better than INBS

INBS Financial Statistics

Sales & Book Value

Annual Sales: $3.11M
Cash Flow: $-3.11M
Price / Cash Flow: 0
Annual Sales: $2.41
Price / Book: 0.71

Profitability

EPS (TTM): -39.55570
Net Income (TTM): $-10.16M
Gross Margin: $1.43M
Return on Equity: -186.3%
Return on Assets: -86.51%

Intelligent Bio Solutions Earnings Forecast

Key Intelligent Bio Solutions Financial Ratios

  • The Gross Profit Margin over the past 3 years for INBS is 45.81%.
  • The Selling, General & Administrative Expenses for INBS have been equal to 297.53% of Gross Profit Margin.
  • The Research & Development expenses have been 53.79% of Revenue.
  • The Interest Expense is -1.65% of Operating Income.
  • The Net Earning history of INBS is -326.40% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

Intelligent Bio Solutions Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: INBS
Website: gbs.inc

Debt

Debt-to-Equity Ratio: 0.06
Current Ratio: 1.57
Quick Ratio: 1.34

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INBS Technical Analysis vs Fundamental Analysis

Sell
34
Intelligent Bio Solutions (INBS) is a Sell

Is Intelligent Bio Solutions a Buy or a Sell?